Rezafungin Acetate not checked
Mundipharma Research Limited · CD101
FollowEvery change as it happens, and a Monday email
Trials
4 active
7 in total · 5 in the EU
What this is
- How it works
- Echinocandin Antifungal FDA class
- How it’s given
- “Rezafungin for infusion. Intravenous anti fungal therapy Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication”In the company’s words, NCT05835479 on ClinicalTrials.gov
- Tested for
- Pneumocystis Pneumonia, Chronic Pulmonary Aspergillosis
- Main trialPhase 2
- “This study aims to generate clinical data on the efficacy, safety, and tolerability of rezafungin combined with 7 days of co-trimoxazole for treatment of Pneumocystis pneumonia (PCP) in adults living with human immunodeficiency virus (HIV), which would expand the knowledge of clinical use of rezafungin.”In the company’s words, NCT05835479 on ClinicalTrials.gov
- Other names
- CD101 · Rezafungin · Intravenous antifungal therapy
Coming up1
- 30 NovPhase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | May 2025 | Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults | |
| Phase 2Active, not recruiting | 30 Nov 2026 | Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options | |
| Phase 3Completed | 29 Jan 2026 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation | |
| Phase 1Completed | Oct 2015 | A Single Ascending Dose Study of CD101 IV in Healthy Subjects | |
| Phase 1Terminated | 23 May 2024 | Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age | |
| Phase 3/4Authorised | not given | Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT) | |
| Phase 4Authorised | not given | Pharmacokinetic Study of Rezafungin in Patients with Suspected Intra-Abdominal Candidiasis: Peritoneal Diffusion and Candicidal Activity |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026